| Product Code: ETC6737826 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to import baricitinib primarily from the USA, India, Japan, Germany, and Belgium. Despite the low concentration of the Herfindahl-Hirschman Index (HHI), indicating a diverse import market, the compound annual growth rate (CAGR) for baricitinib imports from 2020 to 2024 was negative at -7.29%. Furthermore, there was a significant decline in growth rate from 2023 to 2024 at -13.39%, reflecting potential challenges or shifts in the market dynamics for this pharmaceutical product in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Baricitinib Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Baricitinib Market Revenues & Volume, 2021 & 2031F |
3.3 China Baricitinib Market - Industry Life Cycle |
3.4 China Baricitinib Market - Porter's Five Forces |
3.5 China Baricitinib Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Baricitinib Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
3.7 China Baricitinib Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Baricitinib Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rheumatoid arthritis and other autoimmune diseases in China |
4.2.2 Growing adoption of innovative therapies in the healthcare sector |
4.2.3 Government initiatives to improve access to advanced treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High cost associated with baricitinib treatment |
4.3.3 Limited awareness and education about baricitinib among healthcare professionals and patients |
5 China Baricitinib Market Trends |
6 China Baricitinib Market, By Types |
6.1 China Baricitinib Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Baricitinib Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 China Baricitinib Market Revenues & Volume, By DMARDs, 2021- 2031F |
6.1.4 China Baricitinib Market Revenues & Volume, By JAK Inhibitors, 2021- 2031F |
6.2 China Baricitinib Market, By End- Users |
6.2.1 Overview and Analysis |
6.2.2 China Baricitinib Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 China Baricitinib Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 China Baricitinib Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 China Baricitinib Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.2.6 China Baricitinib Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Baricitinib Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Baricitinib Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 China Baricitinib Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 China Baricitinib Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Baricitinib Market Import-Export Trade Statistics |
7.1 China Baricitinib Market Export to Major Countries |
7.2 China Baricitinib Market Imports from Major Countries |
8 China Baricitinib Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on baricitinib in China |
8.2 Percentage of rheumatologists prescribing baricitinib as a treatment option |
8.3 Patient adherence rate to baricitinib therapy |
8.4 Number of partnerships and collaborations between pharmaceutical companies for the development and distribution of baricitinib in China |
8.5 Rate of adverse events reported related to baricitinib use in China |
9 China Baricitinib Market - Opportunity Assessment |
9.1 China Baricitinib Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Baricitinib Market Opportunity Assessment, By End- Users, 2021 & 2031F |
9.3 China Baricitinib Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Baricitinib Market - Competitive Landscape |
10.1 China Baricitinib Market Revenue Share, By Companies, 2024 |
10.2 China Baricitinib Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here